Topics
July/August 2012 | New: The Hot Button
The Impact of Recent Regulatory Decisions Regarding the Iluvien Intravitreal Implant
Robert L. Avery, MD; David M. Brown, MD; and Baruch D. Kuppermann, MD, PhD
August 5, 2026
Vantage Biosciences Completes Enrollment in Phase 2 SeeClear Trial of Oral NPDR Therapy
August 4, 2026
University of Iowa Research Underpins First-in-Human UK Study of Gene Therapy Targeting Rare IRD
Swedish Study Finds Small Absolute Risk of NAION Among GLP-1 Receptor Agonist Users
Opus Genetics Completes Enrollment in Phase 3 Trial of Gene Therapy for Inherited Retinal Disease
July/August 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
July/August 2026 Supplement
Editorially Independent Content, Supported With Advertising From Astellas and ZEISS
July 2026 Supplement
Free Print Subscription
Email Newsletter
Conference Calendar
_1784132761.jpg?auto=compress,format&w=70)
